Medindia

X

PricewaterhouseCoopers Health Industries Launches New Health Reform Website with Analysis of Implications for Health Organizations

Tuesday, April 13, 2010 Press Release J E 4
Advertisement
NEW YORK, April 13 PricewaterhouseCoopers LLP today launched a new website for their Health Industries practice - www.pwc.com/healthreform - which will serve as a central point of access for PricewaterhouseCoopers' latest insight and analysis on the implications of health reform for health organizations including insurers, physicians, hospitals and other providers, pharmaceutical and life sciences companies and employers.

"Embedded within the Health Care and Education Affordability Reconciliation Act of 2010, signed into law on March 30, is a blueprint for a new health system," said Kelly A. Barnes, U.S. health industries leader, PricewaterhouseCoopers. "The implications of this new, comprehensive law - including new taxes, regulations and administrative deadlines - present opportunities and challenges that will affect each of the sectors in the health industries in different ways. Health executives will have to act quickly to plan for the changes ahead and position their organizations for the post-reform world."

Key features of the new website include:

The website will be regularly updated with new insight and sector summaries offering deeper analysis and cross-sector implications and announcement of upcoming events.

About PricewaterhouseCoopers' Health Industries Group

PricewaterhouseCoopers' Health Industries Group (www.pwc.com/healthindustries) is a leading advisor to public and private organizations across the health industry, including payers, providers, academic institutions, health sciences, biotech/medical devices, pharmaceutical companies, employers and new non-traditional market participants in the dynamic healthcare space. PricewaterhouseCoopers has a network of more than 4,000 professionals worldwide and 1,200 professionals in the U.S. dedicated to the health industries and is one of the only firms with a dedicated global healthcare research unit, the Health Research Institute, which provides research-based thought leadership on the impact of business and policy trends.

PricewaterhouseCoopers' Health Industries' clients include 40 of the top 100 hospitals in the U.S. and 16 of the 18 best hospitals as ranked by US News & World Report; all 20 of the world's major pharmaceutical companies; all of the top 20 commercial payers in the U.S.; municipal, state and federal government agencies and many of the world's preeminent medical foundations and associations. Follow PwC Health Industries at http://twitter.com/PwCHealth.

About PricewaterhouseCoopers

PricewaterhouseCoopers (www.pwc.com) provides industry-focused assurance, tax and advisory services to build public trust and enhance value for its clients and their stakeholders. More than 163,000 people in 151 countries across our network share their thinking, experience and solutions to develop fresh perspectives and practical advice.

"PricewaterhouseCoopers" refers to PricewaterhouseCoopers LLP or, as the context requires, the PricewaterhouseCoopers global network or other member firms of the network, each of which is a separate and independent legal entity.

Đ 2010 PricewaterhouseCoopers LLP. All rights reserved.

-- Up-to-date analysis of health industry sector implications and tax changes developed by PricewaterhouseCoopers' Health Research Institute, Washington National Tax Practice, and Human Resource Services practice. -- Webcasts exploring key provisions of health reform, including new care models, accompanying reimbursement changes, and health IT. -- Guide to PricewaterhouseCoopers' health reform industry specialists. -- Link to additional thought leadership and perspectives on the changing health system.

SOURCE PricewaterhouseCoopers LLP
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Delcath's Phase III Trial Data to be Presented Dur...
S
Kendle Executives to Share Insights at 19th Annual...